STERIS plc (STE) Stock
STE has an Alpha Score of 51 out of 100 (weak), computed on Nov 7, 2026 from 3 of 4 sub-scores. 9 members of Congress disclosed 26 trades in STE since 2014: 13 purchases and 12 sales, most recently Kevin Hern (sale, Sep 15, 2026). Company insiders reported 0 open-market buys and 1 sale on SEC Form 4 in the 90 days to Nov 6, 2026. Its trailing P/E ratio is 30.5 and its net margin 13.3% (key statistics as of Nov 6, 2026).
What is STE's Alpha Score?
How it works →Alpha Score of 51 reflects moderate overall profile with strong momentum, poor value, moderate quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Nov 7, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which members of Congress traded STERIS plc (STE)?
Most recent: Kevin Hern (sale, Sep 15, 2026); records start Jul 23, 2014.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Kevin Hern R-OK · House | 2026-09-15 | sale | $15k – $50k |
| April McClain Delaney D-MD · House | 2026-08-25 | sale | $100k – $250k |
| April McClain Delaney D-MD · House | 2026-07-31 | partial sale | $1k – $15k |
| April McClain Delaney D-MD · House | 2026-07-29 | partial sale | $1k – $15k |
| April McClain Delaney D-MD · House | 2026-07-27 | partial sale | $1k – $15k |
| April McClain Delaney D-MD · House | 2026-07-24 | partial sale | $1k – $15k |
| Jared Moskowitz D-FL · House | 2026-07-13 | sale | $1k – $15k |
| Gil Cisneros D-CA · House | 2026-05-13 | purchase | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Nov 5, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.
Every member of Congress who traded STE, with filing lags →Are STERIS plc insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Aug 12, 26 | Sohi Mohsen | Director | SELL | 4.1K | $957K |
SEC Form 4 filings as of Nov 6, 2026
See cluster-buy signals across all tickers →What are STE's key statistics?
Key statistics as of Nov 6, 2026
How does STE's valuation compare with the Healthcare sector?
| Metric | STE | Healthcare median | Companies in median |
|---|---|---|---|
| P/E ratio | 30.5 | 28.8 | 111 |
| Net margin | 13.33% | 4.31% | 164 |
| Return on equity | 11.28% | 5.47% | 185 |
| Dividend yield (payers) | 1.02% | 1.59% | 55 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 7, 2026). P/E excludes loss-making companies.
STE price chart
Powered by TradingViewWhat does STERIS plc do?
STERIS plc is a leading provider of infection prevention and other surgical products and services in the healthcare sector. The company develops, manufactures, and distributes a comprehensive range of sterile processing equipment, consumables, and services designed to help healthcare facilities maintain sterility and safety standards. Its offerings include sterilization systems, washing and decontamination equipment, surgical tables, lights, and endoscopes, along with maintenance and support services. STERIS plc serves hospitals, ambulatory surgery centers, and pharmaceutical manufacturers through its core segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. These segments enable the delivery of critical solutions for reprocessing medical devices, sterilizing single-use medical products, and supporting biopharmaceutical production. Founded in 1985 and headquartered in Dublin, Ireland, STERIS plc plays a vital role in enhancing patient safety and operational efficiency across global healthcare and life sciences markets.